A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)

Hiroyuki Yamaguchi, Kazushige Wakuda, Minoru Fukuda, Hirotsugu Kenmotsu, Hiroshi Mukae, Kentaro Ito, Kenji Chibana, Kohji Inoue, Satoru Miura, Kentaro Tanaka, Noriyuki Ebi, Takayuki Suetsugu, Taishi Harada, Keisuke Kirita, Toshihide Yokoyama, Yuki Nakatani, Kenichi Yoshimura, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Kenji Sugio

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)'. Together they form a unique fingerprint.

Medicine & Life Sciences